All In Biotech

Free tool

FAERS Monitor: Fosamax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020560 or its brand name (Fosamax, Alendronate Sodium). Reports on generic versions are filed under their own applications.

Reports

83,679

Serious

66,990

80% of reports

Hospitalization

32,348

Death reported

10,774

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain13,040
  • fatigue12,258
  • drug ineffective11,759
  • femur fracture11,065
  • arthralgia10,508
  • rheumatoid arthritis10,154
  • alopecia9,989
  • abdominal discomfort9,939
  • systemic lupus erythematosus9,388
  • pemphigus9,118
  • rash8,790
  • glossodynia8,478
  • arthropathy8,299
  • swelling7,864
  • hypertension7,697

Reports by year received

View as table
YearReports
20043,094
20053,438
20063,302
20073,751
20083,254
20093,260
20104,088
20114,620
20128,031
20133,906
20142,882
20152,893
20162,519
20172,434
20182,492
20192,771
20203,385
20214,878
20224,270
20232,985
20244,689
20254,240
20262,496

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,970,480 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal9,118672.9647.21,660,785
glossodyniaSignal8,478152.5148.6794,096
femur fractureSignal11,065139.1136.0976,969
systemic lupus erythematosusSignal9,38890.088.0608,887
arthropathySignal8,29943.943.0296,969
rheumatoid arthritisSignal10,15424.624.1210,357
swellingSignal7,86423.022.5151,994
abdominal discomfortSignal9,93915.815.5130,344
alopeciaSignal9,98913.413.2109,960
hypertensionSignal7,6979.49.256,542
arthralgiaSignal10,5086.56.448,532
painSignal13,0405.45.347,509
rashSignal8,7905.25.129,427
fatigueSignal12,2584.03.928,242
drug ineffectiveSignal11,7592.32.28,671

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.